Finanznachrichten

Intervacc AB: Intervacc and Dechra extend distribution agreement for Intervacc's equine strangles vaccine Strangvac by two years

Intervacc AB (publ) announces today that the five-year distribution agreement signed in April 2021 with its partner Dechra Pharmaceuticals PLC has been extended by two years. The extension will take ...
Finanznachrichten

Intervacc AB: Intervacc has received orders from Dechra Pharmaceuticals with an order value equivalent to approximately SEK 5.8 million

Stockholm, January 16, 2025 - Intervacc AB (publ) has received orders from Dechra Pharmaceuticals with a total order value equivalent to approximately SEK 5.8 million. Orders received relate to ...